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Co-evolution between host and pathogen is, in principle, a powerful determinant of the biology and
genetics of infection and disease. Yet co-evolution has proven difficult to demonstrate rigorously in
practice, and co-evolutionary thinking is only just beginning to inform medical or veterinary research in
any meaningful way, even though it can have a major influence on how genetic variation in biomedically
important traits is interpreted. Improving our understanding of the biomedical significance of co-evo-
lution will require changing the way in which we look for it, complementing the phenomenological
approach traditionally favored by evolutionary biologists with the exploitation of the extensive data
becoming available on the molecular biology and molecular genetics of host–pathogen interactions.
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That pathogens and hosts have evolutionary effects on one
another and that these effects might be reciprocal—that is,
pathogens and hosts co-evolve—are attractive, plausible and
powerful ideas whose implications for the medical and veteri-
nary sciences are only just beginning to be recognized1. An
important instance concerns the genetics of susceptibility to and
pathogenicity of infectious diseases. At one level, co-evolution is
of interest simply as a means of maintaining polymorphisms at
relevant loci2,3. But beyond this, whereas studies of susceptibility
and pathogenicity generally take a static view of the underlying
population genetics, co-evolution is a dynamic process: if host
and pathogen co-evolve, then a ‘good’ gene in one time and place
may be a ‘bad’ gene in another time and place. Failure to recog-
nize the dynamic nature of the interaction could result in misin-
terpretation of its genetic basis.
Whereas there is abundant evidence consistent with co-evolu-
tion from studies of pathogens infecting invertebrates, plants or
bacteria3–7, there is less concerning pathogens of humans and
other long-lived, vertebrate hosts. Although this has been taken
by some to indicate that co-evolution may not be important in
such hosts8–10, an alternative view is that traditional approaches
to looking for co-evolution are too limited, especially when it
takes place against a complex and dynamic background of con-
straints and trade-offs in both host and pathogen. In this
respect, biomedical science may have as much to offer evolu-
tionary biology as vice versa; rapidly accumulating data on mol-
ecular biological and molecular genetic aspects of infectious
diseases are providing new opportunities for studying
host–pathogen co-evolution.
In this review, we assess the evidence for co-evolution in
host–pathogen systems. We then explore the complexities of
studying co-evolution in the ‘real world’, where there are many
different constraints on the potential for pathogen and host to
co-evolve. We proceed to consider the largely untapped oppor-
tunity for studying co-evolution at the mechanistic as well as
the phenomenological level. Finally, we offer some suggestions
for future directions for studies of co-evolution and its bio-
medical significance.
Nature of co-evolution
Definition. We define co-evolution as the process of reciprocal,
adaptive genetic change in two or more species (Fig. 1, Box 1).
This simply means that changes in gene frequencies as a result of
selection acting on one population create selection for changes in
gene frequencies in the other population(s), although the kinds
of population genetic processes that result can be different, as we
detail below. Co-evolution can occur between any interacting
populations: prey and predator, plant and herbivore, competi-
tors or mutualists, but it is expected to be particularly important
in host–pathogen systems because of the intimate nature of the
association and the strong selective pressures that each can exert
on the other4.
Examples of reciprocal traits potentially involved in co-evolu-
tion include pathogen infectivity and host resistance; host-seek-
ing and pathogen-avoidance behaviors; and the ability of the host
to clear an infection versus the ability of the pathogen to evade or
suppress host defenses. In each of these pairings, the effects on the
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good for the pathogen is bad for the host and vice versa. There is a
more ambiguous, though extremely important, relationship
between the pathogen- and host-related components of viru-
lence. Here, we take virulent to mean harmful but not necessarily
highly transmissible, and note that virulence is determined by the
host response to infection as well as by the biology of the
pathogen itself. By definition, virulence is associated with
decreased host fitness, but it may be associated with either
decreased or increased pathogen fitness11,12 or, conceivably, it
may not be of selective significance to the pathogen at all13.
Theory of co-evolution. Theoretical studies of co-evolution date
back over 40 years14,15; examples include ‘gene-for-gene’, ‘match-
ing allele’ and ‘matching genotype’ models16–22. The key feature
of these models is that the outcome of the host–pathogen interac-
tion depends on the combination of host and pathogen genotypes
involved. Other features vary: whether the genome is haploid or
diploid; the number of alleles involved and whether there is
pleiotropy (especially fitness costs independent of the
host–pathogen interaction); dominance relationships between
alleles; the number of loci involved and whether there is epistasis;
whether reproduction is sexual or asexual; whether mating is ran-
dom or assortative; and the relative generation times of host and
pathogen and whether generations are discrete or continuous.
The models predict that co-evolution can occur under a wide
range of conditions, but that many different outcomes are possi-
ble: stable polymorphisms; dynamic polymorphisms with cyclic
or chaotic fluctuations in allele frequencies of varying amplitude;
unstable cycles leading to fixation; or selective sweeps of favorable
alleles to fixation. Here, we focus on two kinds of changes in allele
frequencies, selective sweeps and dynamic polymorphisms, both
involving reciprocal changes in host and pathogen.
Selective sweeps occur when new alleles appear, by mutation
or migration, and eventually become fixed in the population.
These result in transient polymorphisms, although the process
of fixation may be slow (Fig. 2a). Dynamic polymorphisms
involve fluctuations in allele frequencies caused by selection
and are inherently persistent, although fixation can occur as a
result of genetic drift (Fig. 2b). We regard Fig. 2a as represent-
ing an ‘arms race’ (accumulated ‘improvements’ in both popu-


















Fig. 1 Schematic representation of co-evolution, emphasizing reciprocity in
that changes in allele frequencies due to selection in one species impose selec-
tion resulting in changes in allele frequencies in the other. Green arrows indi-
cate intra-specific selection; yellow arrows indicate inter-specific selection.
Box 1 • Glossary
Term Definition
co-evolution Reciprocal, adaptive genetic changes between interacting species. Co-evolution can be studied in terms of
paired phenotypic traits, such as resistance and infectivity, in terms of interacting host and pathogen
molecules or in terms of genes or nucleotide sequences directly.
gene-for-gene Co-evolution involving a single locus in the genomes of each of two interacting populations. The outcome of
the interaction depends on the combination of alleles at these loci.
resistance Genetic, biochemical or physiological characteristics of the host that inhibit pathogen establishment, survival or
development. Resistance may be quantitative, so that hosts may be infected but resistant ones are harmed less,
or qualitative, so that host infection is prevented. The majority of studies of host–pathogen co-evolution regard
resistance as the latter.
infectivity Genetic, biochemical or physiological characteristics of the pathogen that determine its ability to infect the
host. High infectivity does not necessarily mean that symptoms of disease (pathology) appear more quickly, nor
that the illness is more severe (virulence).
virulence The direct or indirect reduction in host fitness attributable to pathogen infection, often measured as pathogen-
induced host mortality. (Conflicting definitions exist, such as that of the infective capacity of pathogens (here 
termed “infectivity”) within plant-pathogen systems.) 
compatibility The ability of a given pathogen to infect a given host, as a consequence of the combined genetic,
biochemical or physiological characteristics that determine infectivity and resistance.
trade-off An unavoidable genetic constraint/negative correlation in which investment in one trait compromises
investment in another.
local adaptation Sympatric combinations (here, of host and pathogen) are more compatible than allopatric combinations.
dynamic polymorphism A selection regime that results in the maintenance of two or more alleles at a locus in a population but with
changing allele frequencies (often cyclic).
selective sweep The process of an advantageous allele increasing to fixation under natural selection. Linked alleles may also go
to fixation by ‘hitch-hiking’.
frequency-dependent Dependence of relative genotypic fitnesses on genotype frequencies. Can be positive or negative. If negative,
selection that is, if the fitness of alleles at a locus declines with increasing frequency, a stable or dynamic polymorphism
may result.
balancing selection Any form of selection acting to maintain alleles in a population, including frequency-dependent selection and
heterozygote advantage.
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(“running as fast as you can to stay in the same place”). Unfor-
tunately, both terms have been used to refer to both processes,
even though their nature, time scale and population genetic
consequences are quite distinct.
Conditions for co-evolution. Co-evolution requires (i) genetic
variation (additive genetic variation for diploid species) in the
relevant host and pathogen traits (ii) reciprocal effects of the
traits involved on the fitnesses of the two populations and (iii)
dependence of the outcome of the host–pathogen interaction
on the combinations of genotypes involved (in multi-locus sys-
tems, this makes epistasis and linkage disequilibrium poten-
tially important).
Evidence of these requirements is needed to demonstrate the
potential for co-evolution. Demonstrating that co-evolution
actually is occurring requires evidence of change (whether direc-
tional or non-directional) in both host and pathogen genotype
frequencies in the field. In practice, such evidence is rarely avail-
able. This is not surprising: demonstrating any kind of ongoing
selection is not straightforward23 and, even though it has long
been believed that pathogens have an evolutionary effect on
hosts24, there are few unequivocal demonstrations of these
effects9,10. Demonstrating co-evolution presents the greater chal-
lenge of demonstrating reciprocal selection in both host and
pathogen. It is likely to be most apparent where (i) a specialist
pathogen exerts a strong selection pressure on its host as well as
vice versa; (ii) the relevant host and pathogen traits have high
heritability and a simple genetic basis; (iii) there are minimal
other constraints on the relevant pathogen and host traits,
including those due to the impact of selection imposed by other
hosts or pathogens, respectively; and (iv) pathogen and host gen-
eration times are short. Because it is so difficult to observe the
process of co-evolution, most studies have been concerned with
demonstrating a pattern of variation in genotypes or phenotypes
that is consistent with either ongoing or past co-evolution.
Evidence for co-evolution
Temporal patterns. There have been few long-term field studies
of host–pathogen co-evolution. The classic example is the Euro-
pean rabbit–myxoma virus system in which, after the virus was
introduced into a naïve rabbit population, phenotypic changes
were observed in both pathogen and host components of viru-
lence25 (Fig. 3a). The rapid, initial attenuation of the virus pre-
sumably represents adaptation to a novel host. But subsequent
slower increases in both virus pathogenicity and the ability of the
host to survive infection are consistent with co-evolution. Other
evidence comes from a snail–trematode system that exhibits fluc-
tuating frequencies of different host clones, such that recently
rare clones are less susceptible to infection with contemporary
pathogens, as expected with Red Queen co-evolution26,27.
Supporting evidence comes from work on model systems.
Studies of foot-and-mouth virus in cell cultures have found
increasing resistance of the cells to the virus, with accompanying
Box 2 • Equations
• Equation 1. Time to fixation during a selective sweep is given by the expression92:
where t is time (in generations), s is selection coefficient (assumed to be small), p0 is initial allele frequency and pt is allele frequency at
time t. A high proportion of selectively advantageous mutations are, however, lost by random sampling when they are still rare; the
chance of survival is approximately twice the selective advantage of their carriers over the rest of the population92.
• Equation 2. An example of a model generating dynamics polymorphisms has the form16:
where Mi is the density of uninfected hosts with genotype i; Pij is the density of hosts of genotype i infected with pathogens of
genotype j; N is the total host density; ri(N) is the density-dependent host population growth rate of genotype i; βij is per capita rate at
which pathogens of genotype j infect hosts of genotype i (and is zero if a particular combination is not compatible); and µ is the per
capita death rate of infected hosts. This is a matched genotype model for sexually reproducing hosts and pathogens.













































Fig. 2 Allele frequency changes driven by co-evolution. a, A series of selective sweeps by host (blue line) and pathogen (red) alleles derived by mutation. Selec-
tion is directional, that is, genetic change accumulates in both populations. At any given stage of the process there may be polymorphisms in either, both or
neither of the two populations. In a large random-mating population, the time to fixation of a favorable variant is proportional to the reciprocal of the selec-
tion coefficient, but depends only logarithmically on the initial gene frequency. See Box 2, Equation 1. b, Dynamic polymorphisms in both host (blue) and
pathogen (red) acting on existing genetic variation. Evolution is non-directional. At all stages of the process both populations are polymorphic. If pathogen
genotypes track host genotypes closely, as illustrated, then sympatric host–pathogen combinations will generally be more compatible than allopatric (that is,
genetically independent) ones: this is local adaptation. Because there is a lag between the cycles in host and pathogen, however, sympatric combinations will
be less compatible than some allopatric combinations: this is local maladaptation. A large range of models predict, at least for certain parameter combina-
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phenotypic changes, and consequent selection for more path-
ogenic virus, with accompanying sequence variation in the
VP1 gene28. Experimental studies of phage infections of
Escherichia coli have shown that changes in a single gene,
LamB, can make the surface of the bacterium refractory to
adsorption by a lytic phage, but that subsequent changes in a
single phage gene can restore the ability of the phage to be
adsorbed29,30. This leads to an arms race which can continue
for a limited number of cycles6,7.
A practical difficulty in demonstrating co-evolution in action
is that the time scales involved may be long, especially for hosts
with long generation times. Unless the selection pressure
imposed by pathogens is severe, selective sweeps can be slow
(Box 2). Even if infection is fatal, selective sweeps by alleles con-
ferring host resistance can still take hundreds of host generations
if the pathogen has a long generation time of its own, such as
scrapie in sheep or HIV in humans31,32.
Spatial patterns. Studies of spatial patterns thought to be consis-
tent with co-evolution are rather more common. This approach
implicitly assumes that spatial subpopulations are at different
stages of a co-evolutionary process, so that spatial variation can
be used to infer temporal variation22. Several theoretical models
predict that sympatric host–pathogen combinations will gener-
ally be more compatible (that is, the pathogen is ‘better’ at infect-
ing the host) than allopatric combinations—this is referred to as
local adaptation—but that occasionally allopatric combinations
will be most compatible—local maladaptation16,22 (Fig. 2b). But
co-evolution need not always lead to local adaptation; for exam-
ple, where virulence is low or migration rates are high22,33.
Local adaptation has been demonstrated in many
host–pathogen systems (Table 1; Fig. 3b) with, as expected, local
maladaptation being more rarely reported (Table 1). Compati-
bility has been shown not just to differ between sympatric and
allopatric populations but to decrease with the distance between
Table 1 • Examples of spatial variation in pathogen–host compatibility11,16,22,26,94
Pathogen Host
Local adaptationa: Microphallus sp. (a trematode) Potamopygrus antipodarum (a snail)
Schistosoma spp. (a trematode) Bulinus globosus (a snail)
Diplostomum phoxini (a trematode) European minnow
Wuchereria bancrofti (a filarial worm) Aedes polynesiensis (a mosquito)
Pleistophora intestinalis (a microsporidian) Daphnia magna (a crustacean)
Bluetongue virus Culicoides variipenis (a midge)
Synchytrium decipiens (a fungus) Amphicarpaea bracteata (an annual plant)
Local maladaptationb: Schistosoma mansoni (a trematode) Biomphalaria tenagophila (a snail)
Haemogregarine parasite Gallotia galloti (a lizard)















































































Fig. 3 Evidence for co-evolution. a, Temporal changes in pathogen and host components of virulence following the introduction of myxoma virus into the Aus-
tralian populations of European rabbits. The virus component (as a weighted index of five case fatality grades among exposed reference laboratory rabbit lines)
and the host component (as the percentage case fatality after exposure to reference laboratory virus isolates) are compared from 1950 onwards. Data are from ref.
25. b, Local adaptation of the parasitic trematode Microphallus sp. to the freshwater snail Potamopygrus antipodarum. Percentage infection (±1 s.e.) resulting
from exposures of all combinations of snails from two different lakes in New Zealand to equal doses of parasites from the same lakes. Sympatric combinations
result in significantly higher percentage infection. Graph was redrawn from ref. 26. c, Decreasing compatibility with distance. Spore loads of the parasitic
microsporidian Pleistophora intestinalis in Daphnia magna exposed to the same dose for combinations of different populations against distance between the host
and parasite populations (log scale). More distant combinations result in significantly lower spore loads, that is, they are less compatible. Graph was redrawn from
ref. 11. d, Strain-specific resistance and susceptibility of the freshwater snail Biomphalaria glabrata to the parasitic trematode Schistosoma mansoni. Percentage
infection (±1 s.e.) of snail lines artificially selected for resistance and susceptibility when exposed to equal doses of different parasite strains. Resistance and sus-
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them (Fig. 3c). Local adaptation has also been found to reflect
relatedness as well as sympatry. For example, a bacterium infect-
ing the water flea Daphnia magna usually shows the highest com-
patibility with the host clones from which it was isolated, but is
occasionally more compatible with novel host clones34.
These patterns are broadly consistent with the predictions of
co-evolutionary theory, but they represent only indirect evidence
and there may be alternative explanations for spatial variation in
compatibility35–37. An important step is to establish that the
observed patterns do indeed have a genetic basis26,38. Even then,
however, it is possible that genetic divergence of local popula-
tions occurs independently of any interactions with other
species. This is the probable explanation of the diversification of
some pathogens within human subpopulations (for example,
Helicobacter pylori, papillomaviruses and JC virus39–41),
although local co-evolution could have occurred. Improved sta-
tistical methods for distinguishing genetic divergence from adap-
tive causes of correlated genetic change across populations42,43
can help interpret observed patterns. But the key point is that
searching for co-evolution relies on the demonstration of recip-
rocal variation in pathogen and host phenotypes (and, ideally,
genotypes too)11,16,26. This constitutes much stronger evidence
than spatial variation in either species alone38.
Complications
Genetic basis. One reason that co-evolution may be difficult to
demonstrate in practice is that the genetic basis of host–pathogen
interactions may be more complex than is represented by the sim-
ple gene-for-gene model. Resistance to pathogens is often a poly-
genic trait, especially in vertebrates44,45. Moreover, there may be a
diversity of genetic mechanisms conferring increased host resis-
tance; for example, there are many different ways in which
humans are resistant to malaria46. And resistance may evolve not
just by the appearance of new alleles at existing loci but through
the accrual of new resistance mechanisms involving other loci17.
Ultimately, it could be argued that many different host genes and,
likewise, many different pathogen genes will have some direct or
indirect influence on the outcome of the interaction, making it
hard to identify the role of individual loci. Demonstrating recip-
rocal selection will be even harder in such situations.
Environmental as well as genetic factors will inevitably influ-
ence host–pathogen interactions and, particularly among verte-
brates, there is the further complication of phenotypic
plasticity47. The most obvious example is the adaptive immune
response, which allows the same genetic machinery to be used to
combat a vast number of different pathogens. And, in humans
and perhaps other species, behavioral plasticity may also amelio-
rate the impact of pathogens. Phenotypic plasticity will reduce
the importance of the host genotype–pathogen genotype inter-
actions that drive co-evolution. The numerous examples of
genetic variation in resistance to infection45 indicate, however,
that environmental variation and phenotypic plasticity do not
preclude evolutionary responses to pathogens.
Costs of resistance. An important complication is that, in the
absence of infection, host resistance may carry a fitness cost,
which may be apparent in such diverse ways as reduced survivor-
ship48, reduced fertility49, reduced competitive ability50 or
increased susceptibility to non-communicable diseases51. A spe-
cial case of a cost of resistance is heterozygote advantage, classi-
cally illustrated by the relationship between human sickle-cell
anemia and susceptibility to malaria: the sickle-cell hemoglobin
allele is homozygous lethal, and heterozygotes are resistant to
malaria46. Heterozygote advantage may arise when the cost of
resistance is recessive, as only the heterozygous effects of rare
alleles are selected for in random-mating populations52.
Costs of resistance have several consequences. On the one hand,
they can allow host polymorphisms to be maintained without any
corresponding genetic variation in the pathogen and so without
any co-evolution, although hosts might not invest in resistance at
all if fitness costs are too high19. On the other hand, costs of resis-
tance in the host coupled with costs of infectivity in the pathogen
can drive co-evolution that would not otherwise occur19,53,
though such costs are not a pre-requisite for co-evolution16,17.
Multiple pathogens, multiple hosts. Studies of co-evolution
typically consider a single host species interacting with a single
pathogen species. But, in reality, most host populations
encounter a large number of different pathogen species54,55, and
most pathogen species can infect more than one species of
host—some can infect hosts from different taxonomic orders or
even classes54. Moreover, multiple infections with different
strains of the same pathogen are common55,56. These multiple
pathogen–multiple host interactions are not independent of one
another, and this can be an important constraint on the potential
for co-evolution.
There are several ways in which pathogen species interact
within a host. At one level, pathogens may simply compete for
host resources, and so directly influence each other’s fitness. This
may include sharing, and competing for, the same host receptors
(Table 2). More subtly, infection with one species may enhance
host susceptibility to another, a common effect known as facilita-
tion, although the converse, inhibition, does occasionally occur
(Table 3). Different pathogen species may not even be genetically
independent: there is increasing evidence of the potential for
genetic exchange between different prokaryote pathogens57,58.
There may also be interactions not just between different
pathogen species within the host but between different geno-
types or strains of the same species. These can have a number of
effects. First, exposure to multiple pathogen strains can itself
result in facilitation59,60, perhaps reflecting the advantages of
antigenic diversity for escaping or overwhelming the immune
response. Second, infections with multiple pathogen strains can
also be differentially virulent56, possibly depending on how
Table 2 • Examples of shared receptor use by viruses68,95,96
Receptor Pathogens
decay accelerating factor echoviruses, Coxsackie viruses
alpha-dystroglycan Lassa fever virus, lymphocytic
choriomeningitis virus
sialic acid wide range including influenza
viruses and some reoviruses
phosphate transporter molecule feline leukemia virus,
some retroviruses
Table 3 • Examples of interactions between pathogens97–101
Facilitation
Positive associations occur between trypanosome and helminth
infections in mice.
Immunosuppressive effects of HIV or malaria can result in various
opportunistic infections.
Helminth infections affect the balance between the different
T cell types, Th1 and Th2, which in turn affects susceptibility to
other infections.
Echinostome infection predisposes snails to schistosome
infection.
Inhibition
Co-infection with hepatitis GBV-C can delay the progression of
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closely the pathogens are related12,44, and can lead to complex
selection pressures for higher or lower virulence61. Third, the
underlying genetics may become more complicated; for example,
different loci may be associated with resistance to different
pathogen strains (Fig. 3d), and there may be epistasis between
resistance genes, which reduces fitness costs associated with resis-
tance to multiple pathogen strains, as has been reported for E.
coli and phage62.
Having multiple hosts also affects the potential of pathogens
to co-evolve with one host. On the one hand, for many
pathogens, adaptation to a particular host population con-
strains its ability to infect other host populations44,61; this is
supported by evidence from serial passage experiments63. There
is even evidence that having a life cycle involving two or more
host species constrains a pathogen’s ability to co-evolve with
either44,64. On the other hand, having multiple hosts may mean
reduced selection pressure for a pathogen to co-evolve with any
one host. If a pathogen can more easily evolve infectivity to a
novel host than evade the resistance selected for in an existing
host, this favors host switching. Although empirical support for
this comes from brood parasites65 rather than pathogens, many
viruses can exploit different host cell receptors, and this can be
associated with host switching66, thereby demonstrating a
potential for co-evolution involving multiple host species. But
only certain pathogens may be capable of infecting multiple
hosts; for example, viruses that use receptors conserved across
different host taxa tend to have broader host ranges67. It is
important to note that not all hosts exert any selection pressure
on the pathogen at all. This particularly applies to ‘accidental’,
‘dead-end’ hosts (for example, humans for Toxoplasma gondii
and Echinococcus granulosis), as these make no contribution to
pathogen reproductive success1.
Clearly, a host population cannot evolve in response to selec-
tion pressure from one pathogen population without affecting
the selection pressures imposed by other pathogens, and a
pathogen population cannot evolve in response to selection pres-
sure from one host population without affecting the selection
pressures imposed by other host populations. The conceptual
models of co-evolution in single pathogen–single host systems
that currently dominate the literature may not always be appro-
priate in a multiple pathogen–multiple host world.
Molecular basis of co-evolution
Molecular interactions. The evidence for co-evolution dis-
cussed so far is phenomenological; an alternative approach is
to look for evidence for co-evolution at the biochemical level.
The molecular biology underlying host–pathogen co-evolu-
tion is, in general, only poorly understood, but there is a huge
literature on molecule-for-molecule interactions between
hosts and pathogens, and these are obvious candidates for co-
evolution (Table 4). A potentially important category is virus
receptors68, many of which are proteins involved in host
immune responses, itself raising interesting questions about
the co-evolution of the immune system and its targets. Func-
tional mimicry of host molecules (for example, Salmonella
SptP mimicking host GAP enzymes or, commonly, mimicry to
evade the immune response69) also raises the possibility of
molecule-for-molecule co-evolution, although there is not yet
evidence that hosts do, or can, respond by evading the mimics.
To date, few recognized host–pathogen molecular interactions
have been examined with co-evolution in mind, but there are
several instances in which studies of underlying patterns of
genetic variation are providing indications of the potential, at
least, for molecular co-evolution. These include studies of
molecular polymorphisms, gene genealogies and positive
selection.
Molecular polymorphisms. Functional polymorphisms are
often found in pathogen genes coding for antigens, that is, mole-
cules that interact with the immune system, but there are also
examples involving other kinds of interaction with the host, such
as with host cell receptors (Table 4). Many host cell receptors for
viruses are themselves polymorphic (Table 4), although this does
not necessarily indicate a potential for co-evolution, as most of
these polymorphisms are to do with inherited disorders and are
not known to affect pathogen infections. Some host genes, how-
ever, are involved with both. An allele of SLC11A1, a gene
involved in macrophage activation, increases resistance to tuber-
culosis but is also associated with autoimmune disease51, illus-
trating that constraints on co-evolution owing to costs of
resistance can be identified at the molecular level. Notably, this
implies that interactions with pathogens can also be important in
the evolutionary origins of susceptibility to non-communicable
as well as infectious diseases1.
These examples concern
polymorphisms in only the
host or only the pathogen,
however; there are few
instances in which reciprocal
molecular polymorphisms
have been identified. One can-
didate is the instance of
human MHC and malaria CS
genes in west African popula-
tions. Different MHC alleles
have different abilities to bind
to a variable region of the CS
protein, and analyses of the
co-distributions of pathogen
and host genotypes are consis-
tent with selection pressures
exerted by each on the other70.
There may also be potential
for molecular co-evolution
between humans and HIV.
Susceptibility to HIV/AIDS
varies across alleles encoding
the CCR5 receptor. The resis-
Table 4 • Potential for molecular co-evolution44,67,68,83,102–105
Examples of molecular interactions
lectins and glycoproteins cytokines and immunosuppressors receptors and toxins
receptors and invasins/adhesins T-cell receptors and antigens cell receptors for viruses
Examples of molecular polymorphisms
Pathogen: lymphocytic choriomeningitis virus glycoprotein (interacts with mouse
alpha-dystroglycan);
measles virus hemagglutinin (interacts with human CD46 and signaling
lymphocyte activation molecule);
malaria circumsporozoite (CS) protein (interacts with human MHC);
human immunodeficiency virus (HIV) env (interacts with human CCR5).
Host: intercellular adhesion molecule 1 (a receptor for Coxsackie A viruses);
CCR5 (a receptor for human immunodeficiency viruses);
MHCs (receptors for many pathogens);
low-density lipoprotein receptors (receptors for hepatitic C virus and bovine
viral diarrhea virus).
Examples of positive selection
Host genes: defensins; immunoglobulins; MHC; ribonucleases; transferrins; proteinase 
inhibitors; interleukins.
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tant alleles are deletion mutants that probably arose several
hundred years ago and appear to have been subject to strong
selection71, possibly caused by another pathogen such as
Yersinia pestis66,72. In addition, variation in the HIV env gene is
associated with variation in infectivity to different CCR5 vari-
ants73,74. There is also some evidence for a potentially co-evolu-
tionary interaction between HIV-1 and human CTL
responses75, although the CTL response also varies indepen-
dently of the pathogen76–78.
Gene genealogies. Phylogenetic methods can be used to trace
the evolutionary histories of alleles implicated in host–pathogen
co-evolution71,79. Alleles differing at few sites have probably
evolved relatively recently, and may represent transient poly-
morphisms (Fig. 2a). In contrast, alleles with large sequence dif-
ferences probably have ancient origins and have been
maintained by selection, possibly imposed by co-evolution. One
possible example is provided by plant R-gene alleles79, although
enhanced variability due to gene conversion between members
of R-gene families may also explain the observed patterns.
Another is the mammalian MHC: some MHC alleles appear to
have been maintained for tens of millions of years80. MHC alle-
les are implicated in host resistance polymorphisms for a wide
variety of pathogens, and are used as receptors by several differ-
ent viruses, so there is potential for dynamic polymor-
phisms81,82. It is unclear, however, whether MHC alleles are
maintained by frequency-dependent selection or by heterozy-
gote advantage9, and to what extent resistance to pathogens is in
fact the main selection pressure. Plant R-genes and mammalian
MHC do suggest, however, that host genetic diversity can be
maintained for extremely long time periods, consistent with
powerful balancing selection, possibly involving interactions
with many different pathogens79,81.
Positive selection. An alternative approach to identifying
potential molecular co-evolution is to look for evidence of
positive selection in genes involved in host–pathogen interac-
tions, the argument being that, if co-evolution accelerates the
accumulation of genetic variation, then positive selection
should be more likely where co-evolution is acting9,79,
although this is not universally accepted83. One way to look for
positive selection involves comparing the ratio of non-synony-
mous (amino acid–changing) to synonymous (silent)
nucleotide substitutions79,83, although interpreting the data is
not always straightforward84,85. But positive selection has been
reported for a wide variety of host genes involved in resistance
to pathogens and also for several pathogen genes (Table 4). A
difficulty is that most genetic variability in pathogens of verte-
brates probably reflects selection of antigens to evade host
immune responses, whose diversity is generated outside the
germ line, and so does not involve true co-evolution. A recent
study of influenza A hemagglutinin did, however, report evi-
dence of positive selection in the receptor binding site as well
as in known epitopes86.
Future of co-evolution
There is evidence consistent with co-evolution, but most of it is
indirect and concerns plant, invertebrate and bacteria hosts. For
vertebrate hosts, especially humans, evidence for co-evolution is
sparser, but there are many indications of potential for co-evolu-
tion and, therefore, its significance is an open and important
question. Part of the problem is that there are many reasons why
demonstrating co-evolution involving vertebrate hosts may be
particularly difficult: lack of understanding of either the genetics
or molecular basis of the host–pathogen interaction; involve-
ment of polygenic traits; fitness constraints on these traits,
including constraints imposed by simultaneous interactions with
multiple hosts or multiple pathogens; phenotypic plasticity; and
the long time scales involved.
One way of addressing these issues is to develop new, more
powerful methods for searching for evidence of co-evolution,
beyond the traditional phenomenological approaches favored by
evolutionary biologists. We suggest that a good starting point is
to identify reciprocal polymorphisms in genes involved in the
host–pathogen interaction at the molecular level—these genes
are obvious candidates for co-evolution. This approach will
require data on nucleotide variation in both pathogen and host
populations87,88, accompanied by use of the battery of tests for
selection that are now available to sequence data23,89. A comple-
mentary approach would be to look for variation in gene expres-
sion during infections of different host genotypes by different
pathogen genotypes. The key is to seek reciprocal variation by
studying host and pathogen in parallel.
There is already abundant evidence for, and huge interest in,
genetic variation in host susceptibility to infectious diseases.
Correctly interpreting this variation requires an understanding
of the potentially dynamic nature of the genetics of the
host–pathogen interaction. If co-evolution is involved, then the
susceptibility of a particular host genotype to an infectious dis-
ease depends on the genotypes of the pathogens to which it is
exposed: an allele conferring protection at one place and time
may have the opposite effect at another.
We anticipate that further evidence will be found for co-evolu-
tion, as is hinted at by the ongoing studies of human interactions
with malaria and HIV discussed earlier. Moreover, we suspect
that the subset of host genes involved in co-evolutionary interac-
tions will turn out to be of particular biomedical importance, as
the examples of mammalian MHC and plant R-genes imply. This
is because they probably determine susceptibility and patho-
genicity, and should provide insights not only into the ways that
host and pathogen adapt and counter-adapt, but, perhaps more
Fig. 4 Illustration of co-evolution between two host populations (blue rectan-
gles) and four pathogen populations (red circles). Pathogens use specific host
receptors (small triangles, squares and circles, matched by shape and color).
Two pathogens compete for the same host receptor; otherwise, the pathogens
use three different host receptors and ‘cooperate’ by facilitating the over-
whelming of the host immune response. The result is a complex web of posi-
tive (arrows) or negative (circles), strong (solid lines, indicating good match to
host receptor) or weak (broken lines, indicating a poor match to host receptor)
interactions between the six populations. Selection for different receptor
expression by the host may alter susceptibility to more than one pathogen
population; selection for different receptor usage by the pathogen may alter
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importantly, into the constraints which prevent either from ‘win-
ning’ the evolutionary battle outright. Moreover, understanding
the responses of pathogens to evolved changes in host character-
istics may provide a good model of their all-too-apparent poten-
tial to respond to other kinds of change, such as the use of new
drugs or vaccines to combat disease63,88,90.
Co-evolution will also have epidemiological implications, par-
ticularly in the context of emerging and re-emerging diseases91.
If co-evolution imposes constraints on susceptibility and patho-
genicity, those constraints may no longer hold when new
host–pathogen associations emerge or ancient associations are
disrupted, affecting both the magnitude and severity of disease
outbreaks. This applies not only when host populations are
exposed to novel pathogens but also when they are exposed to
different populations of existing pathogens. There may also be
indirect effects of changes in the range of pathogens to which a
host population is exposed through altering the selection pres-
sures on existing pathogens (Fig. 4). Altering host genetics, espe-
cially by selective breeding for resistance to a particular
pathogen, could also affect selection pressures on other
pathogens. The deliberate introduction of novel pathogens as a
means of biological control will probably be followed by changes
in the pathogen and, quite possibly, the target host population25.
Recent interest in ‘evolutionary medicine’ represents a
potential starting point for developing these ideas1. But most
evolutionary biologists tend to work at the population level
and pay little attention to the molecular basis of infection and
disease, whereas most biomedical scientists tend to work at the
molecular and cellular level and pay little attention to popula-
tion processes. A fuller understanding of the biological and
biomedical implications of co-evolution demands closer links
between these disciplines than exists at present, but will be
greatly to the benefit of both.
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